InMode Ltd.

InMode Ltd. is a global provider of innovative, energy-based, minimally invasive surgical medical treatment solutions. The company's products primarily address three energy-based treatment categories within the global aesthetics market: face and body contouring, medical aesthetics, and women's wellness. InMode has developed and commercialized products using medically accepted RF energy technology, which can penetrate deep into the subdermal fat for adipose tissue remodeling. InMode's proprietary RF energy-based technologies include Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening, and Deep Heating Collagen Remodeling for skin and human natural openings. Physicians use these technologies to remodel subdermal adipose (fatty tissue) in procedures such as liposuction with simultaneous skin tightening, face and body contouring, ablative skin rejuvenation treatments, and treatment of Genitourinary Syndrome of Menopause (GSM). These products aim to deliver surgical-grade results under local anesthetics while minimizing risks of scarring, downtime, pain, and other complications. In addition to minimally invasive solutions, InMode designs, develops, manufactures, and markets non-invasive medical aesthetic products. These products target procedures such as simultaneous fat destruction and skin tightening, permanent hair reduction using dual wavelength technology, and treatments for skin appearance and texture using high-power IPL technology. InMode's products are marketed and sold to plastic and facial surgeons, aesthetic surgeons, dermatologists, and OB/GYNs, and can be used on various body parts including the face, neck, abdomen, upper arms, thighs, and intimate feminine regions.